Anzeige
Mehr »
Login
Mittwoch, 12.03.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Warum diese Aktie jetzt die Chance auf +100 % Kurspotenzial hat!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
204 Leser
Artikel bewerten:
(1)

Alpha Genesis, Inc.: Monkey See, Monkey Sue: Alpha Genesis Condemns PETA for Filing First Amendment Lawsuit on Behalf of Monkeys

Finanznachrichten News

The lawsuit consumes valuable taxpayer-funded resources.

YEMASSEE, SOUTH CAROLINA / ACCESS Newswire / March 11, 2025 / Alpha Genesis Incorporated (AGI), a globally respected leader in biomedical primate research, strongly condemns PETA's latest legal maneuver: filing a lawsuit claiming First Amendment rights on behalf of monkeys. This baseless claim not only undermines serious legal discourse but also diverts valuable resources funded by hardworking American taxpayers. Instead of addressing real animal welfare concerns, PETA continues to clog the courts with outlandish legal stunts designed to generate headlines.

The lawsuit, which targets the National Institutes of Health (NIH) and other legitimate research institutions, attempts to argue that nonhuman primates should be granted constitutional rights reserved for human beings. "PETA's attack on the NIH is not just legally unsound-it's an attack on the very foundation of scientific progress," said an AGI spokesperson. "NIH researchers dedicate their lives to advancing medicine, developing lifesaving treatments, and improving both human and animal health. This kind of lawsuit distracts from that critical mission, wasting resources that should be focused on real scientific and medical advancements."

Courts have repeatedly rejected similar attempts to assign human rights to animals, with the U.S. judicial system consistently reaffirming that such claims lack merit. "Constitutional protections exist to safeguard the rights of human beings-not to be twisted into political stunts," the AGI spokesperson continued. "If PETA believes that nonhuman primates have the same rights as American citizens, should we make gorillas pay taxes and sign baboons up for jury duty? At this rate, we expect PETA's next lawsuit to demand voting rights for orangutans."

"While PETA diverts attention with legal theatrics, the real scandal is unfolding in PETA's own shelters," the spokesperson added. "Year after year, PETA's own records reveal shockingly high euthanasia rates-tens of thousands of animals, many of them healthy and adoptable, are needlessly put down under their care. Instead of fighting for monkeys to have free speech, PETA should focus on helping the animals entrusted to their own organization."

Alpha Genesis: Advancing Science for Human and Animal Health

While PETA engages in legal theatrics, Alpha Genesis remains at the forefront of scientific discovery. The organization's groundbreaking research in neuroscience, infectious disease, and vaccine development has contributed to significant advancements in medicine and public health. AGI's primate models have played a critical role in:

Vaccine Development: Supporting the creation of life-saving vaccines for diseases such as COVID-19, HIV, and Ebola.

Neurological Research: Advancing the understanding of brain disorders like Parkinson's, Alzheimer's, and autism.

Therapeutic Innovation: Providing crucial insights into new treatments for cancer, autoimmune diseases, and genetic disorders.

The public is encouraged to distinguish between the real-world impact of AGI's scientific contributions and PETA's misguided legal actions that serve only to hinder medical progress.

Contact Information

Dr. Greg Westergaard
President and CEO
gwprimate@alphagenesisinc.com
843-589-5190

.

SOURCE: Alpha Genesis, Inc.



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.